skip to content

Cambridge Immunology Network


Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology.

Alexander SP, Armstrong J, Davenport AP, Davies J, Faccenda E, Harding SD, Levi‐Schaffer F, Maguire JJ, Pawson AJ, Southan C, Spedding MJ. A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development. British Journal of Pharmacology. 2020 May 1.

Read original news article here>